Iontophoresis of treprostinil ( DrugBank: Treprostinil )
1 disease
| 告示番号 | 疾患名(ページ内リンク) | 臨床試験数 | 
|---|---|---|
| 51 | 全身性強皮症 | 2 | 
51. 全身性強皮症
臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment  | Date_ registration  | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor  | Secondary_ sponsor  | Recruitment_ Status  | Inclusion_ agemin  | Inclusion_ agemax  | Inclusion_ gender  | Target_ size  | Phase | Countries | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03120533 (ClinicalTrials.gov)  | June 20, 2017 | 23/3/2017 | Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study | Therapeutic Iontophoresis of Treprostinil in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study | Scleroderma, Systemic | Drug: Iontophoresis of treprostinil;Drug: Iontophoresis of placebo | University Hospital, Grenoble | Linksium;University Grenoble Alps | Completed | 18 Years | N/A | All | 18 | Phase 1/Phase 2 | France | 
| 2 | NCT01554540 (ClinicalTrials.gov)  | February 2012 | 7/2/2012 | Treprostinil Iontophoresis : a Pharmacodynamic and Pharmacokinetic Study | Pharmacodynamic and Pharmacokinetic Assessment of Treprostinil Iontophoresis on the Forearm and the Fingers | Scleroderma, Systemic | Drug: Cutaneous iontophoresis of treprostinil | University Hospital, Grenoble | NULL | Active, not recruiting | 18 Years | N/A | Both | 40 | Phase 1/Phase 2 | France |